SCHEMBL4706113

SCHEMBL4706113

CC(=O)c1c(-c2cccc(F)c2)nn(C(C)C)c(=O)c1Nc1ccccc1Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4B Q07343 1/20 0.38
▸ HTR1A P08908 1/20 0.37
▸ ADRA1D P25100 1/20 0.37
▸ ADRA1A P35348 1/20 0.37
▸ ADRA1B P35368 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ USP2 O75604 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ CSNK1E P49674 6/20 0.36
▸ CSNK1D P48730 4/20 0.36
▸ CRHR1 P34998 1/20 0.36
▸ PIK3CD O00329 1/20 0.36
▸ ABL1 P00519 1/20 0.36
▸ EGFR P00533 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4706564 0.90 RAB9A (0.39) PDE4BHTR1AADRA1DADRA1AADRA1B
SCHEMBL4707571 0.89 PDE4B (0.46) PDE4BHTR1AADRA1DADRA1AADRA1B
SCHEMBL4708003 0.85 PDE4B (0.55) PDE4BHTR1AADRA1DADRA1AADRA1B
SCHEMBL4708887 0.85 PDE4B (0.39) PDE4BMEN1CYP1A2CYP3A4CYP2C9
SCHEMBL4707303 0.83 PDE4B (0.44) PDE4BHTR1AADRA1DADRA1AADRA1B
SCHEMBL4707163 0.82 PDE4B (0.48) PDE4BHTR1AADRA1DADRA1AADRA1B
SCHEMBL6176378 0.82 PDE4B (0.52) PDE4BHTR1AADRA1DADRA1AADRA1B
SCHEMBL4707333 0.81 PDE4B (0.46) PDE4BHTR1AADRA1DADRA1AADRA1B
SCHEMBL6175107 0.81 PDE4B (0.42) PDE4BHTR1AADRA1DADRA1AADRA1B
SCHEMBL3033451 0.80 CSNK1E (0.45) PDE4BCSNK1ECSNK1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7459453-B2 Pyridazin-3(2H)-one derivatives as PDE4 inhibitors LABORATORIOS ALMIRALL, S.A. (ES) 2008-12-02 — — US disclosed
US-20080269235-A1 PYRIDAZIN-3 (2H) -ONE DERIVATIVES AS PDE4 INHIBITORS DAL PIAZ VITTORIO 2008-10-30 — — US disclosed
US-20060052379-A1 Pyridazin-3(2h)-one derivatives as pde4 inhibitors LABORATORIOS ALMIRALL, S.A. (ES) 2006-03-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269235-A1 PYRIDAZIN-3 (2H) -ONE DERIVATIVES AS PDE4 INHIBITORS PDE4A, PDE3A, PDE4B PDE4B 3/4885HTR1A 1051/4885ADRA1D 65/4885
US-20060052379-A1 Pyridazin-3(2h)-one derivatives as pde4 inhibitors PDE4A, PDE3A, PDE4B PDE4B 3/4885HTR1A 1051/4885ADRA1D 65/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback